CHF 5993 (beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CHF 5993 (beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide), covering 2024-10-31 to 2024-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR® [Phase 1]